Oct 25 2024
A new study has found that cannabidiol (CBD) may help alleviate behavioral and neuroinflammatory challenges in adult offspring born to obese mothers. “Maternal obesity is known to increase the risk of psychiatric disorders, such as anxiety, depression, schizophrenia and autism spectrum disorder in the offspring”, notes the study’s abstract. “While preventive measures are well-documented, practical approaches …
Oct 25 2024
A recent study published in Pediatric Reports by researchers from Florida Atlantic University provides a comprehensive look into the evolving patterns of marijuana use among U.S. adolescents over the past decade. Using data from the biennial Youth Risk Behavior Survey from 2011 to 2021, which covered 88,183 students in grades 9 through 12, the study …
Oct 24 2024
A recent observational study published in the Journal of Pain & Palliative Care Pharmacotherapy suggests that patients with fibromyalgia (FM) experience significant symptom improvement when using cannabis-based medicinal products (CBMPs). Conducted by researchers from Imperial College London and Kings College London, the study followed 148 patients enrolled in the UK Medical Cannabis Registry who used …
Oct 22 2024
A retrospective study published in the Asian Spine Journal suggests that patients with a history of cannabis use may require fewer opioids after lumbar fusion surgery. Conducted by researchers from Rosalind Franklin University of Medicine and Science, University of Illinois, Yale School of Medicine, and the University of Cincinnati School of Medicine, the purpose of …
Oct 21 2024
According to the results of a new study, phytocannabinoids derived from marijuana, cannabidiol (CBD) and tetrahydrocannabinol (THC), may help manage emotional comorbidities often associated with epilepsy, including anxiety and fear responses. Researchers observed that seizures led to increased anxiety- and fear-like behaviors in rats, but these effects were reversed by administering CBD (via vapor) and …
Oct 21 2024
A study published recently in the peer reviewed journal Molecular Psychiatry found that psilocybin, a psychedelic compound, may help reduce heroin-seeking behavior. Researchers from Temple University conducted experiments to investigate the potential therapeutic effects of psilocybin on opioid addiction, particularly focusing on relapse behavior following heroin self-administration. In the study, rats were given heroin at …
Oct 18 2024
A new study from Georgia State University, published in the journal Drug and Alcohol Dependence, shows that there continues to be issues with misrepresentation of MDMA in unregulated markets across the United States, although there has been improvements in recent years. The research analyzed 4,719 alleged MDMA samples submitted to the DrugsData drug-checking service, aiming …
Oct 18 2024
A study set to be published in the journal Archives of Oral Biology in January 2025 explores the potential biological effects of cannabidiol (CBD) on oral squamous cell carcinoma cells. Conducted by researchers from the University of Perugia in Italy, the study examines CBD as a possible adjuvant therapy in cancer treatment. The study was …
Oct 18 2024
A recent study published in the Canadian Journal of Microbiology demonstrates that the cannabis compound cannabidiol (CBD) may effectively inhibit the growth of Candida albicans, a yeast commonly associated with infections such as oral candidiasis. Researchers treated C. albicans with varying concentrations of CBD, ranging from 0 to 20 µg/mL, and observed a significant reduction …
Oct 17 2024
An early economic analysis published in the journal Expert Review of Pharmacoeconomics & Outcomes Research suggests that medical marijuana could provide notable cost savings when treating chronic pain. The study assessed the cost-effectiveness of cannabis-based medicinal products (CBMPs) compared to other treatment options, such as analgesics, physiotherapy, and cognitive behavioral therapy, over a one-year period …
